Urology Times, Mar 1, 2006 - UrologyTimes

ADVERTISEMENT

Urology Times

ADVERTISEMENT

Urology Times, Mar 1, 2006
Pick a different issue
News
New names for pelvic pain could advance treatments
By Penny Allen
Past terminology has held management back, Dr. Baranowski argued. The 'itis' of prostatitis, for example, has encouraged patients to seek anti-inflammatory or long-term antibiotic therapies that often don't help.
New test finds UTI cause in 45 minutes; 98% accurate
By Patricia M. Fernberg
Los Angeles--A new biosensor technology that can identify the bacterial cause of urinary tract infections with 98% accuracy within 1 hour may help both clinicians and patients by closing the gap between diagnosis and appropriate treatment.
Genetics could explain chronic pelvic pain
By Penny Allen
Baltimore?What causes chronic pain in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)? This could be the wrong question to ask, said Jeffrey S. Mogil, PhD, at the NIDDK-sponsored Chronic Pelvic Pain/Chronic Prostatitis Scientific Workshop. The better question may be: Why do these particular men have chronic pain, whereas others do not?
IL-8 may offer early tool for finding nosocomial UTI
By Lawrence M. Prescott, PhD
Washington--Results from a small study demonstrate that urinary interleukin-8 (IL-8) can be used as an early diagnostic tool for nosocomial urinary tract infections, Mexican infectious disease specialists said during a presentation at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy here. IL-8 appears to offer a faster alternative to quantitative cultures, according to the researchers.
Data find increase in UTIs caused ESBL-E coli
By Lawrence M. Prescott, PhD
Washington--Over a 5-year study period, researchers have documented a significant increase of extended-spectrum beta-lactamases producing Escherichia coli (ESBL-E coli) isolated from urinary tract infections in both hospital and community settings.
Opiate use in nonmalignant pain: Not a simple dichotomy
By Penny Allen
The use of opiates in chronic nonmalignant pain has its share of proponents and opponents among urologists who specialize in chronic pelvic pain.
'Significant' link found between ED, heart disease
By Mary Beth Nierengarten
San Antonio--Recently published prospective evidence strongly supports the growing recognition among physicians that erectile dysfunction may be a sign of future cardiovascular disease in some men.
Clinicians urged to adopt new model of chronic pain
By Penny Allen
Baltimore--Scientific thinking about pain in general and chronic pain in particular has changed drastically in the last 50 years. Providers who treat chronic pain syndrome, such as chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), need to discard the old models if they are going to help patients.
E coli 'magic bullet' continues to elude scientists
By Charles Bankhead
Washington--Increasing rates of fluoroquinolone-resistant urinary isolates of Escherichia coli have occurred against a backdrop of genetic variability, as no predominant variant has emerged as the principal culprit in resistance, according to a study of medical centers across the United States and Canada.
Second oral agent is approved for advanced RCC
By Cheryl Guttman Krader
New York--The FDA has granted approval of oral sunitinib malate (Sutent), a multi-targeted receptor tyrosine kinase inhibitor, for the treatment of advanced renal cell carcinoma. The approval came after a priority review and was based on results from two phase II clinical trials dem-onstrating impressive drug activity measured by high partial response rates and delay to disease progression. It marks the second FDA approval of a drug for advanced RCC in as many months.
Data suggest sources of chronic, acute pain differ
By Penny Allen
Baltimore--As the focus on pelvic pain syndromes moves away from the organs to the nervous system, researchers such as Ursula Wesselmann, MD, PhD, are trying to find out how acute pain develops into chronic pain.
Urine test boosts detection of recurrent bladder cancer
By Lisette Hilton
Rochester, NY--A point-of-care assay that measures the nuclear matrix protein NMP22 in urine significantly improves detection of recurrent bladder cancer when used with cystoscopy, according to a new study.
E coli urinary isolates likely multi-drug resistant
By Charles Bankhead
Washington--Outpatient urinary isolates of Escherichia coli that exhibit resistance to a fluoroquinolone antibiotic are likely to be resistant to multiple classes of antibiotics, results of a large North American laboratory study suggest.
Pelvic pain shows range of effects on sexual function
By Penny Allen
In one study, 85% of the CP/CPPS patients had decreased frequency of sexual contact because of their pain, 67% said it interfered with or ended relationships, and 43% said it inhibited forming new relationships.
Neurophysiologic tests for CP/CPPS show promise
By Penny Allen
Baltimore?Someday, you may be using neurophysiologic testing for follow-up and possibly even diagnosis of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) before you turn to the four-glass or modified test. That's because, increasingly, CP/CPPS is being recognized not as a disorder of the prostate, but as a neurologic disorder?a chronic pain syndrome that may begin in the viscera, but becomes a nervous system disorder as pain is centralized.
Psychological therapies may benefit CP/CPPS patients
By Penny Allen
Baltimore--Psychological treatment, particularly cognitive behavioral therapy, can help ease chronic pain. That's why these therapies may be able to do the same for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients, argued Judith Turner, PhD, at the NIDDK-sponsored Chronic Pelvic Pain/Chronic Prostatitis Scientific Workshop here.
Hands On
Prostate biopsy: Lessons from the Prostate Cancer Prevention Trial
By Ryan K. Berglund, MD , Eric A. Klein, MD
Prostate cancer is more prevalent than anticipated in patients with a normal DRE and a PSA <4.0 ng/mL.
Coding and Reimbursement
Secure contracts with nursing homes to ensure payment
By Ray Painter, MD
How do I charge for a patient sent from a nursing home for a consult who, upon evaluation, required a cystoscopy?
New Products & Services
New Products & Services
Fiber is cleared for use with Holmium laser in BPH
Product Preview
The Independent Data Monitoring Committee for the phase II trial of Nymox Pharmaceuticals' NX-1207, a novel drug treatment for BPH, has recommended continuation of the multicenter trial on the basis of unblinded re-sults to date.
The Bottom Line
Going paperless: Tips for implementing an EMR
By Neil H. Baum, MD
EMR implementation success depends on solid preparation.
Washington and You
CMS fails to use AUA data in practice expense RVU update
By Bob Gatty
Washington--When 2006 began, there was somewhat of a mess in Washington involving Medicare reimbursement, and that was especially true for urologists. At press time, some of those issues were being resolved, but, even so, there will likely be fallout that will at least inconvenience urologists and their staffs.
Perspective
Chronic pain: It's time to think outside the box
By Anthony J. Schaeffer, MD
Researchers are taking a broader view of chronic pain that will allow development of new treatment strategies.
Money Matters
Private foundations may help you manage donations
By Joel M. Blau, CFP
In order to ensure that private foundations are truly legitimate charitable entities, they are subject to numerous complex tax rules.

ADVERTISEMENT

Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Dermatology Diagnosis
Dermatology Diagnosis

Identify skin diseases by age, gender, location. Start Here

AHRQ Clinical Guidelines
AHRQ Clinical Guidelines

Objective findings on medical interventions. Start Here

ADVERTISEMENT



Click here